ICD-10 Coding for Endoscopic Ultrasonography Biopsy of Adrenal Gland(C74.9, C74.9U, C79.7)
Learn about the ICD-10 coding and documentation requirements for endoscopic ultrasonography biopsy of the adrenal gland, including primary and secondary codes.
Complete code families applicable to Endoscopic Ultrasonography Biopsy of Adrenal Gland
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C79.7 | Secondary malignant neoplasm of adrenal gland | When biopsy confirms metastatic disease in the adrenal gland. |
|
| E27.8 | Other specified disorders of adrenal gland | When biopsy confirms a benign adrenal condition. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEndoscopic Ultrasonography Biopsy of Adrenal Gland
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Endoscopic Ultrasonography Biopsy of Adrenal Gland.
Missing documentation of needle gauge/passes
Impact
Clinical: Inadequate documentation for clinical validation., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation
Standardize procedure note templates, Regular training on documentation requirements
Incorrectly coding primary adrenal cancer as metastatic.
Impact
Reimbursement: May lead to incorrect billing and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Affects accuracy of cancer registry data.
Mitigation
Verify biopsy results and imaging to confirm metastatic nature.
Documentation of FNA details
Impact
Failure to document FNA specifics can lead to audit issues.
Mitigation
Ensure thorough documentation of procedure details.